Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer.

CONCLUSION: An EPA-enriched oral supplement may be effective in advanced pancreatic cancer.
PMID: 33438442 [PubMed - as supplied by publisher]

Source: Nutrition and Cancer - January 13, 2021 Category: Cancer & Oncology Authors: Ueno M, Sugimori K, Taguri M, Ohkawa S, Kobayashi S, Miwa H, Kaneko T, Morimoto M, Yamanaka T Tags: Nutr Cancer Source Type: research